Treatment effectiveness can have different meanings to patients,” a physician assistant said when discussing therapy for high ...

A poll of experts revealed that few are utilizing talquetamab for patients with pretreated relapsed/refractory myeloma.

Cilta-cel led to high response rates and a promising safety profile in a real-world population of patients with relapsed/refractory myeloma. A nurse practitioner discusses her role in caring for ...

After a patient with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer experiences disease progression ...

Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer ...

Perioperative pembrolizumab plus chemotherapy improves overall survival in patients with resectable gastric cancer. Final results of the ARMANI trial demonstrated that switch maintenance therapy with ...

Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer ...

Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd ...

Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer ...

Extensive-stage (stage IV) SCLC, on the other hand, is a disease that has spread outside the bounds of 1 radiation field, and ...